INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.760
+0.070 (4.14%)
Jul 30, 2026, 3:18 PM EDT - Market open
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $46.79 million as of July 30, 2026. Its market cap has decreased by -44.30% in one year.
Market Cap
46.79M
Enterprise Value
26.94M
1-Year Change
-44.30%
Ranking
Category
Stock Price
$1.76
ChartMarket Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $46.79M, a decrease of -39.88%. That is a compound annual growth rate of -6.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 46.79M | 12.82% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 48.88M |
| Instil Bio | 48.49M |
| Mereo BioPharma Group | 48.22M |
| BeyondSpring | 48.11M |
| aTyr Pharma | 48.01M |
| Edesa Biotech | 47.57M |
| Seres Therapeutics | 46.97M |
| Impact BioMedical | 46.58M |